Due to the COVID-19 pandemic, the global DNA Sequencing Instruments market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe DNA Sequencing Instruments market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe DNA Sequencing Instruments landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Emulsion PCR accounting for % of the DNA Sequencing Instruments global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Molecular Biology segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of DNA Sequencing Instruments include Roche, Johnson & Johnson, Illumina, Life Technologies, Beckman Coulter, Pacific Biosciences, Oxford Nanopore, GE Healthcare Life Sciences and Abbott Laboratories. etc. In terms of revenue, the global 3 largest players have a % market share of DNA Sequencing Instruments in 2021.
This report focuses on DNA Sequencing Instruments volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall DNA Sequencing Instruments market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global DNA Sequencing Instruments Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Emulsion PCR
Bridge Amplification
Single-molecule
Segment by Application
Molecular Biology
Evolutionary Biology
Metagenomics
Medicine
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Roche
Johnson & Johnson
Illumina
Life Technologies
Beckman Coulter
Pacific Biosciences
Oxford Nanopore
GE Healthcare Life Sciences
Abbott Laboratories